Despite such heterogeneity, CD33 emerged as the only marker that is expressed on the cell surface of virtually every BMMC from individual patients of every subtype of SM even though greater expression levels were found in indolent SM and WDSM vs. advanced SM (i.e., ASM, SM-AHN and MCL). The gene discussed is CD33; the disease is systemic mastocytosis.